NATURE’S SUNSHINE PRODUCTS, INC. Available-for-sale Securities, Gross Realized Gains
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Available-for-sale Securities, Gross Realized Gains of $294.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGains · last filed 2015-11-06
- NATURE’S SUNSHINE PRODUCTS, INC. available-for-sale securities, gross realized gains for the quarter ending 2015-09-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. available-for-sale securities, gross realized gains for the quarter ending 2014-09-30 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gains 3 month | Available-for-sale Securities, Gross Realized Gains 6 month | Available-for-sale Securities, Gross Realized Gains 9 month |
|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $294.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $294.00K 10-Q · filed 2015-08-10 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |